Suppr超能文献

基质金属蛋白酶(MMP)和尿激酶型纤溶酶原激活剂(uPA)系统的差异表达及其在食管鳞状细胞癌中的表达与预后的相关性

Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.

作者信息

Yamashita Keishi, Tanaka Yoichi, Mimori Koshi, Inoue Hiroshi, Mori Masaki

机构信息

Department of Surgical Oncology, Medical Institute of Bioregulation, Kyushu University, Beppu, Japan.

出版信息

Int J Cancer. 2004 Jun 10;110(2):201-7. doi: 10.1002/ijc.20067.

Abstract

Matrix metalloproteinase (MMP) is critical for carcinoma progression. In our study, we evaluated the prognostic significance of the major MMP family such as MMP-3, MMP-9, MMP-11 and MT1-MMP at the mRNA in 44 esophageal squamous cell carcinoma (ESCC) that were previously characterized for MMP-7, MMP-1 and MMP-2, and their relation to urokinase system (uPA and uPAR). MT1-MMP, MMP-11 and MMP-2 expressions are closely associated with each other, while MMP-9 and uPAR expressions are inversely associated with the former group. There is no MMP related to clinicopathological factors; however, patients with high MT1-MMP could show worse prognosis, as compared to those with low MT1-MMP expression (p=0.01), as well as MMP-11 did (p=0.02). Both MMP showed clear expression of carcinoma cells by immunohistochemistry. In patients with high MT1-MMP, recurrence was more prominent (23/26: 88.5%) than those with low MT1-MMP (7/18: 38.9%) (p=0.0016). In the 20 cases who died within 3 years, all 15 cases with high MT1-MMP showed initial recurrence of distant metastasis, and the other 5 cases with low MT1-MMP showed locoregional recurrence (p=0.000064). These results could indicate that there is a relevant mechanism of associated expression of clinically significant MMP and that among them, MT1-MMP plays the most critical role in ESCC progression.

摘要

基质金属蛋白酶(MMP)对癌症进展至关重要。在我们的研究中,我们评估了主要MMP家族(如MMP - 3、MMP - 9、MMP - 11和MT1 - MMP)在44例食管鳞状细胞癌(ESCC)中的mRNA水平的预后意义,这些病例之前已对MMP - 7、MMP - 1和MMP - 2进行了特征分析,以及它们与尿激酶系统(uPA和uPAR)的关系。MT1 - MMP、MMP - 11和MMP - 2的表达彼此密切相关,而MMP - 9和uPAR的表达与前一组呈负相关。没有MMP与临床病理因素相关;然而,与MT1 - MMP低表达的患者相比,MT1 - MMP高表达的患者预后可能更差(p = 0.01),MMP - 11也是如此(p = 0.02)。通过免疫组织化学,两种MMP在癌细胞中均显示出清晰的表达。MT1 - MMP高表达的患者复发比MT1 - MMP低表达的患者更显著(23/26:88.5%)(7/18:38.9%)(p = 0.0016)。在3年内死亡的20例患者中,15例MT1 - MMP高表达的患者均出现远处转移的初始复发,另外5例MT1 - MMP低表达的患者出现局部区域复发(p = 0.000064)。这些结果可能表明存在临床上重要的MMP相关表达的相关机制,其中MT1 - MMP在ESCC进展中起最关键的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验